The latest closing stock price for Terns Pharmaceuticals as of November 20, 2024 is 5.60.
An investor who bought $1,000 worth of Terns Pharmaceuticals stock at the IPO in 2021 would have $-695 today, roughly -1 times their original investment - a -25.71% compound annual growth rate over 4 years.
The all-time high Terns Pharmaceuticals stock closing price was 27.25 on March 19, 2021.
The Terns Pharmaceuticals 52-week high stock price is 11.40, which is 103.6% above the current share price.
The Terns Pharmaceuticals 52-week low stock price is 3.59, which is 35.9% below the current share price.
The average Terns Pharmaceuticals stock price for the last 52 weeks is 6.89.
An investor who bought $1,000 worth of Terns Pharmaceuticals stock at the IPO in 2021 would have $-695 today, roughly -1 times their original investment - a -25.71% compound annual growth rate over 4 years.
The all-time high Terns Pharmaceuticals stock closing price was 27.25 on March 19, 2021.
The Terns Pharmaceuticals 52-week high stock price is 11.40, which is 103.6% above the current share price.
The Terns Pharmaceuticals 52-week low stock price is 3.59, which is 35.9% below the current share price.
The average Terns Pharmaceuticals stock price for the last 52 weeks is 6.89.